1. Introduction {#s0005}
===============

Liver cirrhosis is known to manifest in systemic effects. In particular, the most common neurological manifestation of liver cirrhosis is hepatic encephalopathy (HE), which comprises a variety of symptoms. Patients suffering from HE exhibit alterations in cognitive and motor function as well as behavioral changes. The clinical symptoms of HE vary with disease severity, starting with mild attentional deficits and disorientation, cognitive deterioration, and disturbed motor control. They may develop into somnolence and stupor and in the most severe case hepatic coma ([@bb0020]; [@bb0060]; [@bb0065]; [@bb0225]).

The pathophysiology of HE is not finally understood, but is assumed to be multifactorial ([@bb0050]; [@bb0060]; [@bb0090]). A key element in the pathophysiology is the invasion of ammonia into the brain through the blood-brain barrier. Previous studies using ^13^NH~3~-PET imaging have revealed an increased uptake of circulating ammonia into the brain of cirrhosis patients ([@bb0120]; [@bb0170]).

In addition to increased oxidative stress caused by ammonia accumulation ([@bb0210]), an excess of glutamine is produced in the astrocytes as a result of ammonia detoxification by glutamine synthetase. The increased glutamine concentration in the astrocytes triggers cell swelling *via* osmotic imbalance, finally leading to alteration of brain water homeostasis and emergence of a low-grade edema ([@bb0055]; [@bb0085]). The emergence of a low-grade edema was further investigated by different studies using advanced MR imaging: Quantitative T~1~ mapping and semi-solid magnetization transfer (MTC) imaging studies attributed increased T~1~ values ([@bb0260]) and alterations in the calculated MTC effect ([@bb0200]) to increased water content in HE patients. Additionally, a quantitative water mapping approach has demonstrated a small increase of water content in white matter areas ([@bb0265]), while these findings remained absent in another quantitative water mapping study including patients with low-grade HE ([@bb0220]). In general, T~1~-weighted ([@bb0030]; [@bb0145]; [@bb0230]; [@bb0240]) or quantitative T~1~ ([@bb0260]) imaging may be altered by increased water content. However, T~1~ changes especially within the basal ganglia are more likely to be mediated by manganese deposition, which is a common neurotoxin in HE ([@bb0235]).

All MR visible effects described above are based on the notion of ammonia accumulation in the patients\' brains. Therefore, it is of paramount interest to measure ammonia in a most direct way, without the use of radiation, and with increased resolution compared to ^13^NH~3~-PET imaging.

Chemical exchange saturation transfer (CEST) represents a suitable tool for the assessment of changes of *in vivo* ammonia levels. CEST provides an advanced MRI contrast depending on diluted labile protons, which are usually undetectable by conventional MRI. The CEST contrast is based on the mitigation of the bulk water signal due to magnetization transfer between the bulk water and frequency-selectively saturated labile protons ([@bb0295]). Amide proton transfer-weighted (APT~w~) imaging, which is based on magnetization transfer from exchangeable amide protons of mobile tissue proteins and peptides ([@bb0110]), is an emerging field in CEST imaging. It allows several applications, such as amide proton quantification, detection of pH changes in the amide proton environment ([@bb0205]; [@bb0275]; [@bb0340]), and measurement of global *in vitro* protein folding ([@bb0080], [@bb0075]) with possible applications in neurodegenerative diseases. Additionally, CEST depends on non-exchange-related factors, such as direct water saturation, MTC, and water longitudinal relaxation time ([@bb0360]). Thus, these factors have to be included in the interpretation of possible HE related changes in APT~w~ imaging.

In our recent *in vitro* study, we were able to link increasing ammonia concentrations to a decreasing APT~w~ CEST signal through protein denaturation ([@bb0355]). We could also apply this finding to example cases of HE patients. The present study aimed to systematically investigate the sensitivity of APT~w~ imaging to HE-related brain ammonia levels, and to gauge its potential to monitor disease severity and progression *via* the HE-related signal alteration in APT~w~ imaging. To this end, APT~w~ imaging was performed in a cohort of clinically well-characterized HE patients in different grades of severity, as well as healthy age-matched controls. To investigate the relationship between disease severity and APT~w~ imaging, the critical flicker frequency (CFF), psychometric testing scores, and blood ammonia levels were assessed. In addition, T~1~ maps were acquired to control for T~1~ effects on the measured MTR~asym~ values by T~1~ normalization in the region-of-interest analysis.

2. Material and methods {#s0010}
=======================

2.1. Participants and HE grading {#s0015}
--------------------------------

The study was performed in accordance with the Declaration of Helsinki in its current version ([@bb0300]), and was approved by the local institutional review board (study number 5179R). All participants gave written informed consent prior to the examination. 15 controls and 20 patients with clinically confirmed HE, graded as minimal HE (mHE) and manifest HE (HE), were examined. Exclusion criteria for both patients and controls included neurological or psychiatric diseases excluding the diagnosis of HE for the patient group, severe intestinal diseases, the use of any medication acting on the central nervous system and diagnosed peripheral/retinal neuropathy. If alcohol abuse was part of the medical history, the patient had to remain abstinent for ≥4 weeks prior to examination. The grading was performed in line with the *West-Haven* criteria ([@bb0065]; [@bb0135]). In addition, neuropsychological testing, critical flicker frequency (CFF) assessment with portable CFF goggles (NEVOlab, Maierhöfen, Germany), and blood sample tests were carried out. In the CFF test, the tested individual has to indicate with a button press when the impression of a virtual light source in 12 m distance changes from a fused light source to a flickering one. After a short training session, the CFF is assessed eight times, and the mean and standard deviation are calculated for further analysis. The CFF was included as it has been shown to be a reliable clinical parameter for HE monitoring, and accounts for the continuous nature of symptom severity ([@bb0140], [@bb0135]). One control had to be excluded due to a CFF value \<39 Hz, which is the cut-off frequency for mHE. The remaining study population is summarized in [Table 1](#t0005){ref-type="table"}.Table 1Remaining study cohort.Table 1NSex \[M/F\]Age \[years\]\
Mean ± SDCFF \[Hz\]\
Mean ± SDEtiology of liver cirrhosisControls148/660.1 ± 5.344.2 ± 3.4--mHE107/355.1 ± 10.441.0 ± 3.2[⁎](#tf0005){ref-type="table-fn"}5 ALC, 1 HCV, 1 NASH, 1 OS, 2 UHE106/459.5 ± 6.736.4 ± 2.3[⁎⁎](#tf0010){ref-type="table-fn"}5 ALC, 2 HCV, 2 NASH, 1 OS[^1][^2]

HE severity was determined by an experienced clinician and included a clinical assessment regarding the mental state and consciousness of the patients and neuropsychometric testing. Computer-based neuropsychometric tests from the Vienna Test System (Dr. Schuhfried GmbH, Mödling, Austria) consisted of five test batteries and reported 22 age-validated scores (percentile rank values in comparison to an age-matched control cohort) reflecting motor and cognitive performance. Better performance was graded with higher scores. The parameter values were considered as abnormal in case of a percentile rank lower than 15.9 compared to the control cohort implemented in the test system. Patients without clinical symptoms of manifest HE, but with \>1 abnormal psychometric test result were classified as mHE ([@bb0135]). Selected scores were incorporated for further analysis, including cognitive (COG1: time to reject a geometric shape not matching control shapes; COG2: time to confirm a geometric shape matching a control shape), fine motor performance (line following test: LVT1: time per item; LVT2: overall score), motor/precision/speed (MLS1: hand steadiness/tremor; MLS2: arm/hand precision; MLS3: arm/hand speed; MLS4: finger tapping speed), and reaction performance (WRT1: reaction time; WRT2: motor reaction time) scores.

2.2. MR measurements {#s0020}
--------------------

All MR investigations were performed on a clinical whole-body 3 T MRI (Siemens MAGNETOM Trio A TIM System, Siemens Healthcare AG, Erlangen, Germany) using a 12-channel head coil for receive, and the internal body coil for transmit.

### 2.2.1. Structural MRI {#s0025}

Following a scout scan, a high-resolution 3D anatomical transversal T~1~-weighted magnetization prepared gradient echo (MP-RAGE) scan (TR/TE = 1950/4.6 ms; isotropic resolution of 1 mm; 176 slices) was performed aligned to the AC-PC line.

### 2.2.2. CEST MRI {#s0030}

The CEST images were acquired using a prototype transversal 3-dimensional gradient echo sequence (TR/TE = 1390/3.06 ms; flip angle = 10°; FoV = (230 × 230) mm^2^; matrix size 192 × 192; 24 slices; slice thickness 5 mm; gap 1 mm) to obtain full brain coverage. 22 equidistant frequency offsets were sampled between −5 and 5 ppm using a pulse train of 5 Gaussian shaped pulses (pulse duration 100 ms; inter pulse delay 100 ms, B~1~ = 1.5 μT) for saturation.

The unsaturated S~0~ image was acquired by turning off the saturation pulse. Additionally, data for B~0~ inhomogeneity correction with a water saturation reference map (WASSR) ([@bb0130]) were recorded.

### 2.2.3. GRE MRI {#s0035}

Two 3-dimensional gradient echo scans with different flip angles (FA = 4°, 15) were acquired with the same spatial dimensions as the CEST images. Relative B~1~ maps were created by heavily smoothing the low flip angle (FA = 4°) volume ([@bb0245]). In addition, T~1~ maps were calculated using the volumes (FA = 4°, 15°) ([@bb0245]) leading to a measurement time of 25 min in total.

2.3. Data processing {#s0040}
--------------------

### 2.3.1. Motion correction and brain masking {#s0045}

Motion correction was performed using the co-registration method of the MATLAB (MathWorks Inc., Natrick, MA, USA) toolbox SPM12 ([@bb0070]). The 3D volumes of the CEST datasets of each saturation frequency were co-registered to the 3D volume of the 3.5 ppm saturation frequency, as described by Zhang et al. ([@bb0330]). Subsequently, all WASSR datasets were co-registered to the S~0~ volume. Tissue compounds and cerebrospinal fluid (CSF) were segmented with the SPM *newSegment* function, and a brain mask was created, which included all pixels with probabilities \>0.8 for grey matter (GM), white matter (WM), and CSF.

### 2.3.2. MTR~asym~ evaluation {#s0050}

*Z*-spectra and magnetization transfer ratio asymmetry (MTR~asym~) images were calculated for all pixels within the brain mask using an in-house written MATLAB script. All images were smoothed using a nonlocal means (NLM) filter to improve the signal-to-noise ratio, and to avoid blurring of the images ([@bb0310]). The used filter is a MATLAB reimplementation (<https://de.mathworks.com/matlabcentral/fileexchange/52018-simple-non-local-means-nlm-filter>) of the NLM filter described by Manjón et al. ([@bb0180]). The filtered pixel value is calculated by the weighted average of all pixels in the image. The weights originate from the similarity between the user-defined neighborhood of the filtered pixel and are defined by an exponential decay control parameter h and the Gaussian weighted Euclidian distance of the pixels in the neighborhood. The parameters within the MATLAB toolbox were chosen as follows: search window *t* = 3, similarity window f = 2, standard deviation of the Gaussian low-pass h1 = 0.01, decay control parameter h2 = 18 = 1.18σ with σ being estimated from the noise standard deviation of the background of all images. The factor 1.18 is suggested in the original publication to be optimal for proton-density weighted images. More details are described in Manjón et al. ([@bb0180]).

The *Piecewise Cubic Hermite Interpolating Polynomial* (pchip) algorithm was chosen in the *interp1* MATLAB to interpolate the spectra in steps of 0.05 ppm. Asymmetry analysis ([@bb0335]) was calculated as follows:$$\begin{array}{l}
{MTR_{asym} = Z_{ref} - Z_{lab}} \\
{\mspace{54mu} = Z\left( {\Delta\omega_{ref} = - \Delta\omega_{lab}} \right) - Z\left( {\Delta\omega_{lab}} \right)} \\
{\mspace{54mu} = \frac{S\left( {\Delta\omega_{ref} = - \Delta\omega_{lab}} \right) - S\left( {\Delta\omega_{lab}} \right)}{S_{0}}} \\
\end{array}$$

With labelled proton scan Z~lab~, a reference scan at the opposite frequency Z~ref~ and the unsaturated image S~0~.

MTR~asym~ curves were calculated over a frequency range between 0 and 5 ppm within the z-spectra. Subsequently, the APT-weighted MTR~asym~ maps were calculated by averaging over a frequency range from 3 to 4 ppm and it will be referred to as APT~w~ imaging. B~1~-one-point-contrast correction is performed as described in detail by Windschuh et al. ([@bb0290]). Additionally, T~1~ normalization of the MTR~asym~ was performed in the region-of-interest (ROI) analysis to correct for a T~1~ relaxation effects ([@bb0350]). It will be referred to as APT~w~^T1^ MTR~asym~.

### 2.3.3. Normalization {#s0055}

Data normalization was performed with the open-source software package *Advanced Normalization Tools* (ANTs) ([@bb0005]). The package includes algorithms for bias correction, template construction, and image normalization. A template from the current study population was created with the ANTSNormTemp.sh script using the structural images ([@bb0010]). The script uses an iterative approach including two steps: At first, all individual structural images are spatially transformed onto one reference image. Initially, an average of all structural images was used as reference and 15 iterative steps of affine transformations were performed to align the volumes. In the second step, the inverse transformation matrix is applied to the reference image to update its shape. These two steps are applied iteratively, starting with the updated reference image of the previous iteration. Subsequently, 15 diffeomorphism transformations were performed iteratively with a *Greedy Syn* algorithm to create the template. The maximum iterations (parameter *-m*) within the registrations were as followed: Iterations 1 to 5 with *-m 30 × 90 × 40*, iterations 5 to 10 with *-m 60 × 180 × 80 × 45* and iteration 10 to 15 with *-m 120 × 360 × 160 × 90*. The step size of the image registrations in every sub iteration (−m) decreased with each level. Afterwards, all individual scans were normalized to the template using the diffeomorphism transformation, and the transformation matrix was applied to the CEST and T~1~ maps. Thus, all individual CEST and T~1~ maps could be assessed with an atlas-based statistical analysis.

2.4. Statistical evaluations {#s0060}
----------------------------

### 2.4.1. Atlas-based analysis {#s0065}

The APT~w~ images and T~1~ maps were analyzed by an atlas-based approach, using the Neuromorphometrics atlas integrated in SPM12 ([@bb0070]). The atlas was co-registered to the cohorts template obtained from ANTs. A set of 6 regions including both hemispheres at once was included in the analysis. The regions are summarized in [Table 2](#t0010){ref-type="table"} and the selection was based on their suggested involvement in HE pathophysiology as referenced in previous studies ([@bb0040]; [@bb0155]; [@bb0220]; [@bb0240]; [@bb0260], [@bb0265]). Group level differences (control, mHE, HE) in APT~w~^T1^ MTR~asym~ were investigated with a pairwise non-parametric Wilcoxon rank sum test. Group differences were considered significant for *p* \< .05.Table 2Atlas based statistics of APT~w~^T1^ MTR~asym~ in HE (minimal HE (mHE), manifest HE (HE)).Table 2T~1~ normalized MTR~asym~ (%)\
Mean (± SD)Correlation withControlPatientsCFFBlood ammoniaGGTmHEHEr\
pr\
pr\
pCerebellum0.94\
(0.48)0.92\
(1.16)**0.61**^**\#**^\
**(0.75)**0.043\
0.807**−0.615**\
**0.007**−0.251\
0.300Occipital cortex0.82\
(0.60)0.88 (0.50)**0.39\***\
**(0.50)**0.102\
0.564**−0.478**\
**0.045**−0.267\
0.269Putamen0.61\
(0.11)**0.76\***\
**(0.09)**0.81\
(0.24)**−0.423**\
**0.013**−0.285\
0.252−0.393\
0.096Thalamus0.43\
(0.08)0.45\
(0.08)0.48\
(0.18)−0.323\
0.062−0.365\
0.137**−0.454**\
**0.049**Caudate0.35\
(0.12)0.37\
(0.13)0.42\
(0.16)−0.200\
0.257−0.221\
0.379−0.008\
0.975White matter0.49\
(0.08)0.51\
(0.12)0.57\
(0.14)−0.231\
0.190−0.409\
0.137−0.048\
0.847[^3]

Relationships between CFF and APT~w~^T1^ MTR~asym~, blood ammonia and APT~w~^T1^ MTR~asym~, and between psychometric scores and APT~w~^T1^ MTR~asym~ were compared with a bivariate two-sided Pearson correlation test. Correlations were considered significant in case p \< .05. No multiple comparison correction was employed in the analysis.

All statistical analyses were performed using IBM SPSS Statistics for Windows, Version 24.0 (IBM Corp., Armonk, NY, USA).

3. Results {#s0070}
==========

All 34 MRI datasets (14 controls, 10 mHE, 10 HE) remained in the final analysis. The manifest HE group included 9 HE I patients and one patient graded as HE II. One HE I patient did not undergo psychometric testing, and two patients did not undergo blood testing (1 mHE, 1 HE).

3.1. APT~w~ atlases {#s0075}
-------------------

Mean group APT~w~ atlases are depicted in [Fig. 1](#f0005){ref-type="fig"}. The atlases indicate decreasing APT~w~ MTR~asym~ in the cerebellum and the occipital region of the manifest HE patients. In addition, slight alterations in deep grey matter regions are occurring, as APT~w~ MTR~asym~ increases within the Putamen. An absence of changes is visible for caudate, thalamus, and the selected white matter region.Fig. 1Mean group atlases of APT~w~ MTR~asym~ in healthy controls and HE patients. The rows depict three representative slices including the six selected regions of interests (ROI) (Red: Cerebellum; Yellow: Occipital cortex; Cyan: Putamen; Magenta: Thalamus; Green: Caudate; Blue: White matter). The template of the current study population is depicted in the first column. ROI are illustrated in the second column. The last three columns display the mean atlases of the APT~w~ imaging of each group (control, minimal HE (mHE), manifest HE (HE)). The signal reduction could either be linked to increased ammonia accumulation or hepatocerebral degeneration.Fig. 1

Supplementary Fig. 1 represents the mean APT~w~ atlases, as well as the corresponding slices of mean T1 atlases. To avoid any contamination of APT~w~ effects by water longitudinal relaxation, a T~1~ normalization was performed in the ROI based analysis. Group results and correlations with critical flicker frequency (CFF), blood ammonia, and gamma-glutamyltransferase (GGT) concentration are summarized in [Table 2](#t0010){ref-type="table"}. The ROI based analysis is summarized in the following sections. The figures are focused on the ROI with significant differences in the measured APT~w~^T1^ MTR~asym~.

3.2. Cerebellum {#s0080}
---------------

Mean cerebellar APT~w~^T1^ MTR~asym~ values were reduced in HE patients compared to mHE patients (*p* \< .05; [Fig. 2](#f0010){ref-type="fig"}a) indicating higher levels of ammonia or hepatocerebral degeneration in the patients with manifest HE compared to minimal HE. No differences were found between controls compared to both patient groups. A negative correlation of cerebellar APT~w~ imaging blood ammonia levels (r = −0.615; p = .013; [Fig. 2](#f0010){ref-type="fig"}b) and a positive correlation with the psychometric MLS1 (hand steadiness / tremor) score (*r* = 0.466; *p* = .044; [Fig. 2](#f0010){ref-type="fig"}c) were found. Furthermore, a positive correlation of the psychometric WRT2 score and mean APT~w~^T1^ MTR~asym~ could be observed (*r* = 0.523; *p* = .022; [Fig. 2](#f0010){ref-type="fig"}d).Fig. 2APT~w~ imaging of the cerebellum in healthy controls and HE patients (minimal HE (mHE), manifest HE (HE)). (a) Group boxplots including mean APT~w~^T1^ MTR~asym~ values. Asterisks indicate significant differences between groups (*p* \< .05). Correlations between blood ammonia levels (b), psychometric MLS1 score (hand steadiness/tremor) (c), psychometric WRT2 score (motor reaction time) (d), and mean APT~w~^T1^ MTR~asym~. The data suggests a strong cerebellar involvement in HE explaining poor motor performance of HE patients, which could possibly be linked to ammonia accumulation or hepatocerebral degeneration.Fig. 2

3.3. Occipital cortex {#s0085}
---------------------

A decrease in mean APT~w~^T1^ MTR~asym~ was observed between controls and HE patients (p \< .05), whereas no significant differences were detected between controls and mHE patients and between both patient groups ([Fig. 3](#f0015){ref-type="fig"}a). A negative correlation of occipital APT~w~ imaging and blood ammonia levels (*r* = −0.476; *p* = .045; [Fig. 3](#f0015){ref-type="fig"}b) and a positive correlation with the psychometric MLS2 (arm/hand precision) score (*r* = 0.544; *p* = .016; [Fig. 3](#f0015){ref-type="fig"}c) were present. A positive correlation of occipital APT~w~ imaging and psychometric MLS2 (arm/hand precision) score (r = 0.544; p = .016; [Fig. 3](#f0015){ref-type="fig"}c) and a negative correlation with blood ammonia levels (r = −0.476; p = .045; [Fig. 3](#f0015){ref-type="fig"}b) were present. Additionally, a positive correlation between the psychometric LVT1 score and the mean APT~w~^T1^ MTR~asym~ was found ([Fig. 3](#f0015){ref-type="fig"}d).Fig. 3APT~w~ imaging of the occipital cortex in healthy controls and HE patients (minimal HE (mHE), manifest HE (HE)). (a) Group boxplots including mean APT~w~^T1^ MTR~asym~ values. Asterisks indicate significant differences between groups (*p* \< .05). Correlations between blood ammonia levels (b), psychometric MLS2 score (arm/hand precision) (c), psychometric LVT1 score (time per item) (d), and mean APT~w~^T1^ MTR~asym~ values. This might explain alterations in visual perception of HE patients with increasing diseases severity due to ammonia accumulation.Fig. 3

3.4. Putamen {#s0090}
------------

Mean putaminal APT~w~^T1^ MTR~asym~ were increased in mHE patients compared to controls (p \< .05), whereas no differences were found between controls and HE patients and between the two patient groups ([Fig. 4](#f0020){ref-type="fig"}a). Additionally, the mean values in the HE patient group showed a greater variability. A negative correlation of CFF and APT~w~^T1^ MTR~asym~ was observed ([Fig. 4](#f0020){ref-type="fig"}b). In contrast to the cerebellar and occipital region, the increased putaminal APT~w~^T1^ MTR~asym~ suggests the domination of other contrast mechanism, such as increased glutamine concentrations, in this region. Alterations through increased water or the accumulation of manganese were ruled out by T~1~ normalization.Fig. 4APT~w~ imaging of the putamen in healthy controls and HE patients (minimal HE (mHE), manifest HE (HE)). (a) Group boxplots including mean APT~w~^T1^ MTR~asym~. Asterisks indicate significant differences between groups (p \< .05). (b) Correlation between critical flicker frequency (CFF) and mean APT~w~^T1^ MTR~asym~ values. The data suggests the domination of other contrast mechanisms, such as metabolite concertation changes.Fig. 4

3.5. Psychometric testing {#s0095}
-------------------------

Results of the correlation analysis of the psychometric tests are summarized in [Table 3](#t0015){ref-type="table"}. The motor score MLS1 and the motor reaction time score WRT2 correlated positively with the APT~w~^T1^ intensities in the cerebellum. This indicates a connection between motor deficits of HE patients and reduced APT~w~^T1^ MTR~asym~ in the cerebellum. The line following scores LVT1 and LVT2, the motor scores MLS2 and MLS3, as well as the motor reaction time WRT2 correlated positively with the observed APT~w~^T1^ intensities in the occipital cortex.Table 3Correlations of psychometric test scores and mean APT~w~^T1^ MTR~asym~ (COG1: time to reject a geometric shape not matching control shapes; COG2: time to confirm a geometric shape matching a control shape; line following: LVT1: time per item; LVT2: overall score; MLS1: hand steadiness/tremor; MLS2: arm/hand precision; MLS3: arm/hand speed; MLS4: finger tapping speed; WRT1: reaction time; WRT2: motor reaction time). Bold numbers indicate significant correlations.Table 3COG1COG2LVT1LVT2MLS1MLS2MLS3MLS4WRT1WRT2r\
pr\
pr\
pr\
pr\
pr\
pr\
pr\
pr\
pr\
pCerebellum0.1640.1620.2990.277**0.466**0.4430.3570.1560.282**0.523**0.5030.5080.2130.250**0.044**0.0580.1330.5250.243**0.022**Occipital cortex0.3780.400**0.5470.469**0.399**0.5440.526**−0.0920.356**0.531**0.1100.089**0.0150.043**0.091**0.0160.021**0.7080.019**0.019**Putamen−0.093−0.1050.3180.3910.314−0.034−0.0130.258−0.1390.2850.7040.6680.1840.0980.1910.8900.9580.2860.5690.237Thalamus−0.070−0.1020.1240.1850.1810.2720.1810.038−0.0560.1880.7760.6780.6140.4490.4580.2600.4580.8760.8210.441Caudate−0.335−0.381−0.150−0.1460.151−0.174−0.3010.384−0.3730.0050.1610.1080.5390.5520.5380.4760.2100.1040.1160.985White matter−0.140−0.1700.0380.1140.2360.3560.108−0.0210.0020.0990.5670.4880.8760.6430.3300.1350.6590.9300.9940.688

4. Discussion {#s0100}
=============

In the present *in vivo* CEST study, we applied chemical exchange saturation transfer imaging to investigate the link between hepatic encephalopathy, blood ammonia levels, and APT~w~ measures which reflect cerebral ammonia levels. Our results reveal reduced APT~w~^T1^ MTR~asym~ within the cerebellum and occipital regions correlating both with blood ammonia and psychometric scores. Additionally, APT~w~ intensities are increased within the putamen of mHE patients. Furthermore, putaminal APT~w~^T1^ MTR~asym~ correlates negatively with CFF.

4.1. CEST and clinical parameters in HE {#s0105}
---------------------------------------

Psychometric testing, CFF, and blood ammonia are common clinical parameters to assess the severity of HE, especially in cases of minimal HE, when no clinical overt signs of HE are apparent ([@bb0140]). Decreased fine motor abilities in HE patients are reflected in decreased MLS1 score, which correlate with APT~w~^T1^ MTR~asym~ in the cerebellum in the present work. Increased ammonia accumulation or hepatocerebral degeneration, reflected in decreasing APT~w~^T1^ MTR~asym~, might be associated with these findings. This notion tallies previous findings demonstrating that cerebellar damage is linked to sensorimotor deficits ([@bb0195]) and slower upper limb movements ([@bb0185]). In minimal HE, motor impairments manifest in decreasing finger movement frequency and increasing movement amplitudes even prior to alterations in psychometric test scores ([@bb0035]). Therefore, APT~w~^T1^ MTR~asym~ could shed light on cerebellar alterations leading to impaired motor performance in HE. An additional hint to this interpretation is the correlation with the motor reaction time (WRT2) score.

The contrast mechanisms behind APT~w~ imaging are assumed to be multifactorial and are a matter of debate in the literature today. Possible confounders are changes in pH ([@bb0345]), water content and water T1 ([@bb0165]), and concentration changes in metabolites and proteins ([@bb0320]), as well as altered protein conformation within intracellular protein compounds ([@bb0075]), to mention a few. These factors are discussed further in 4.3. Based on our previous study and the supplementary data (Supplementary Fig. 2) we assume changes in the protein structure to be the main contributor to the observed contrast change in our study. Whether these changes are mediated through direct conformational changes in the protein structure or indirect mechanisms of ammonia, however, cannot be disentangled with the present findings. Thus, hepatocerebral degeneration ([@bb0280]; [@bb0305]) might contribute to the signal reduction in APT~w~ images in more severe HE affecting the cerebellum specifically ([@bb0025]). Cerebellar degeneration in HE is characterized by loss of Purkinje cells, and alcoholic abuse is associated with a greater degree of severity of loss of these cells, and a higher HE prevalence ([@bb0155]). In light of the etiology of our patient cohort (50% alcoholic liver cirrhosis, 50% non-alcoholic etiology), APT~w~^T1^ MTR~asym~ may be altered by an alcohol-induced high degree of cell loss in the cerebellum. Moreover, the appearance of Alzheimer type II astrocytes is likely in those patients ([@bb0155]). These cells undergo morphological changes and thus, might alter the APT~w~^T1^ MTR~asym~ by changing the number of exchangeable amide groups within the measurement volume. Further *in vitro* CEST studies including different cell types with HE-related morphological changes might unravel their specific contribution to our findings at hand.

Previous studies reported an involvement of the visual cortex in HE. This includes worse performance in CFF tests ([@bb0140]), reduced visual GABA/Cr levels ([@bb0215]), abnormal neuronal activity in resting-state fMRI of the visual cortex ([@bb0045]), slowed frequency of of alpha and gamma band oscillations recorded with MEG ([@bb0015]; [@bb0115]), and alterations in visual evoked potentials ([@bb0325]). This involvement is reflected in significant reduction of APT~w~ signals within the occipital cortex and its correlation with the psychometric scores. Increased ammonia accumulation, reflected by decreasing APT~w~^T1^ MTR~asym~, could lead to an impairment of visual perception through neurotransmitter imbalance by ammonia detoxification. A link to CFF was only found within the putamen. This could be due to the fact of relatively large dispersion of the measured APT~w~ MTR~asym~ signals. The strong correlation of blood ammonia levels with APT~w~ signals in cerebellum and occipital cortex substantiates our findings as markers for HE severity.

Further liver disease related markers from the blood test, such as gamma-glutamyltransferase (GGT) concentrations displayed significant correlation with APT~w~^T1^ signals in the thalamus. Future CEST studies including larger number of patients and especially patients at higher diseases stage (HE II) may help better clarifying links between clinical parameters and APT~w~ signals in different brain regions.

4.2. Ammonia in HE {#s0110}
------------------

The multifactorial nature of the pathophysiology of HE includes several alterations in brain metabolism, which interact with the APT~w~ imaging contrast. A key role in the pathophysiology is attributed to the invasion of ammonia in the patients\' brains ([@bb0050]; [@bb0090]). At physiological pH levels, ammonia remains invisible to the classical CEST approach, due to its high exchange rate. Nevertheless, our recent study could demonstrate a link between ammonia concentration and APT~w~ MTR~asym~ protein signal ([@bb0355]).

*In vitro,* the contrast mechanisms were mainly driven by an induced protein denaturation through ammonia, while contrast mechanisms remained unclear in the *in vivo* cases ([@bb0355]). Our data describes APT~w~ signal reductions in the cerebellum and the occipital cortex of HE patients, including correlations with blood ammonia levels and psychometric test scores. A possible interpretation is to link this reduction to an increased ammonia load in these regions, as we already assumed in our *in vitro* experiments.

Our findings are in line with an earlier ^13^NH~3~-PET study ([@bb0120]) depicting a correlation between blood ammonia and the metabolic flux of ammonia. In this work, the metabolic flux was defined as the product of the netto metabolic clearance in blood from intracellular metabolites and arterial ammonia concentration, which was deduced from radioactively marked ammonia. Intracellular glutamine is linked to ammonia removal through glutamine synthase within the brain. As APT~w~ signal predominantly reflects intracellular protein compounds we assume the contrast changes in our study to be mediated through ammonia within the astrocytes, which is underlined by comparable correlations in cerebellum and cortex ([@bb0120]). Therefore, we speculate APT~w~ signal to reflect the metabolic flux of ammonia. At present, a more elaborate differentiation of ammonia kinetic remains inaccessible with APT~w~ imaging as it is measured without contrast agents and reflects an averaged metabolism during the whole acquisition. In the present study, we found an increased APT~w~ signal in the putamen and a negative correlation with the CFF, which is in contrast to the findings reported by Keiding et al. for the basal ganglia ([@bb0120]). This result indicates the potentially larger contribution of another contrast mechanism in this region. Such changes might be driven by increased manganese levels within the basal ganglia ([@bb0060]; [@bb0090]; [@bb0225]; [@bb0235]; [@bb0240]).

Earlier PET studies ([@bb0120]; [@bb0170]) also reported increased cerebral metabolic rates and radioactivity of ammonia in the thalamus, respectively. Additionally, thalamic volume changes were found *via* voxel-based morphometry studies in HE ([@bb0175]). In the present study, thalamic APT~w~ signals only correlated with GGT concentrations. Firstly, increased glutamine concentrations could interfere with the effect of ammonia, which is complementary to our additional phantom experiments (Supplementary Fig. 2). Secondly, the changes in thalamic volume could alter the APT~w~ signal due to changes in the protein concentration. Thirdly, the changes in APT~w~ signal could be dominated by hepatocerebral degeneration, which possibly differs between various regions. Yet, these explanations need to remain speculative.

Ammonia detoxification by glutamine synthase triggers the accumulation of glutamine within astrocytes ([@bb0060]; [@bb0090]; [@bb0225]). Several studies reported disturbance in glutamate/glutamine balance, such as increasing glutamine concentrations after chronic liver failure in rat models ([@bb0270]), and elevated glutamine concentrations in basal ganglia ([@bb0200]) and cortical brain regions of HE patients ([@bb0095]; [@bb0150]; [@bb0215]). Glutamine and glutamate are both CEST-sensitive, and resonate between 3 and 4 ppm ([@bb0255]).

As a result, signal contributions of both metabolites might interact with the APT~w~ mechanism used in this study. In this case, the increasing APT~w~ signal and the negative correlation with the CFF in the putamen could be interpreted as increased glutamate + glutamine (Glx) ratios. In additional phantom experiments (Supplementary Fig. 2), we found that ammonia dominates the contrast mechanism with its presence, by adding *in vivo* realistic glutamate, glutamine (control and HE concentrations), and ammonia concentrations in one solution.

Besides, a 3 T system does not have a high sensitivity to depict changes in either glutamate or glutamine ([@bb0160]), but showed sensitivity to ammonia load in protein based solutions ([@bb0355]). Hence, the underlying mechanisms in the putamen remain unclear, but are likely to be linked to HE disease severity.

4.3. CEST-sensitive confounders {#s0115}
-------------------------------

Starting from APT~w~ imaging, we adapted our saturation parameters in two ways ([@bb0355]). In *in vitro* experiments, the saturation parameters were selected to maximize the contrast gained from the effect of ammonia on the protein signal. Then, these saturation parameters were used to create full brain coverage within the *in vivo* measurements. *In vitro,* we were able to link the alterations in APT~w~ signals directly to ammonia, but *in vivo,* ammonia could only be one of a few contributors to the alterations. Another physiological change described for HE is the osmotic imbalance, which is triggered through the ammonia depletion. Finally, alterations in brain water homeostasis and the emergence of a low-grade edema are reported ([@bb0085]). Regarding the MR visibility of these changes, one study reported water content changes of about 2% in several brain regions including the putamen ([@bb0265]), whereas an absence of MR visible water content changes was reported in another study in HE patients in less severe stages ([@bb0220]).

Several APT~w~ CEST studies at 4.7 T and 7 T emphasize that water content plays a minor role in the contrast formation of APT only ([@bb0125]; [@bb0165]). However, as the APT~w~ values were normalized by the T1 relaxation time, any possible T1 effect can be neglected.

Quantitative T~1~ ([@bb0260]) and T~1~-weighted ([@bb0030]; [@bb0145]; [@bb0230]; [@bb0240]) changes are known to be a key finding in MR imaging of hepatic encephalopathy. To rule out the contamination of our MTR~asym~ we employed a T~1~ normalization, which resolves in pure APT~w~ contrast mechanisms. In addition, a recent study claimed that MTR~asym~ of amide protons at the saturation parameters (B~1~, t~sat~) used in the present study is roughly insensitive to water longitudinal relaxation time ([@bb0360]).

4.4. Limitations {#s0120}
----------------

One limitation of the present study is the number of included patients. As our data suggests that the APT~w~ signals are strongly altered in manifest HE, the inclusion of more patients in the higher HE grade could have strengthened our findings. However, the inclusion of patients in higher disease stages is hard to achieve, as patient compliance is needed both to perform psychometric testing and to achieve sufficient quality of MR data without a substantial amount of movement artifacts.

Another limitation is the number of analyzed ROIs, which included prior knowledge and assumptions within the analysis and led to the fact that some effects might be missed in other brain regions. Thus, all interpretations remain descriptive in the first place and final conclusions about affected brain regions and APT~w~ imaging as marker for HE severity have to be confirmed in future larger studies. In addition, the inclusion of larger cohorts would allow the implementation of non-parametric voxel based analysis ([@bb0105]). This technique excludes user-biased ROI analysis and could give further insight in the disease progression and spatial distribution of HE-related changes. Nevertheless, the present study indicates that APT~w~ imaging is a possible marker for HE, as correlations with HE-related clinical markers were evident.

The sensitivity of the CEST technique is another limitation and a possible explanation for the absence of thalamic alterations in the present study. As discussed above, several confounders to the APT~w~ signal remain elusive, which could lead to increasing type II error rates. In future studies, a combination of MRS with the CEST technique could shed light on the underlying contrast mechanisms. By using the voxel-based acquisition technique EXPRESS ([@bb0285]) in combination with J-difference-edited MEGA-PRESS spectroscopy ([@bb0190]) or a novel accelerated spectral editing sequence allowing the measurement of multiple compounds at the same time in the same brain region ([@bb0250]), the interplay between neurotransmitter metabolism (GABA, glutamate, glutamine), osmolytes (myo-inositol), oxidative stress markers (glutathione), and changes in the protein signals could be investigated. These studies may focus on alterations in cerebellum and thalamus, as the interplay of metabolism and HE is yet unclear in these regions. Additional acquisition of water references would further allow drawing conclusions about water content.

To reach sufficient acquisition times and full brain coverage, relatively short saturation times, small numbers of saturation frequencies, and a non-steady state acquisition were chosen in the present study. Faster imaging sequences would allow improving those parameters, which could even include steady-state CEST measurements within the acquisition. As a result, further correction of the CEST signal could be implemented, such as AREX ([@bb0320]) or EMR ([@bb0100]). More advanced quantification approaches like Lorentzian fitting ([@bb0315]) could also improve data quality and strengthen the findings. Additionally, a Lorentzian fitting model could be able to distinguish between APT, Nuclear Overhauser effect (NOE), and MTC, if a suitable model is chosen. Apart from the fact that ammonia only affects the APT exchange in *in vitro* experiments ([@bb0355]), some *in vivo* studies reported MTC to be altered in HE patients ([@bb0200]). Moreover, morphological changes might affect the NOE, thus Lorentzian fitting could give further insight to the underlying contrast mechanisms in HE. It was not implemented in the current study, as it requires a large number of saturation frequencies leading to long total acquisition times. The implemented MTR~asym~ analysis combined with the full brain coverage already permits the distinction between controls and patients, based on APT~w~ signal alterations in several brain regions.

5. Conclusions {#s0125}
==============

Hepatic encephalopathy is associated with a region-specific decrease of APT~w~ signals, in particularly in the cerebellum and the occipital cortex. These signal changes are linked to increased blood ammonia concentrations, and clinical scores of cognitive and motor function. These variations are most likely a consequence of hyperammonemia or hepatocerebral degeneration processes and develop in parallel with disease severity. Therefore, APT~w~ CEST imaging could be a possible tool to investigate HE and advance the understanding of region-specific alterations in HE and its clinical equivalents. By including additional methods to quantify metabolite levels and water content, the interplay between metabolism and protein signal alterations in HE could be assessed in more detail in future studies.
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[^1]: Significantly different from controls (*p* \< .05) with non-parametric Wilcoxon rank sum test.

[^2]: Significantly different from controls (*p* \< .01) and mHE (p \< .01) with non-parametric Wilcoxon rank sum test (*ALC* alcoholic, *HCV* hepatitis C virus, *NASH* non-alcoholic steatohepatitis, *OS* overlap syndrome, *U* unknown).

[^3]: Asterisks indicate significant differences from controls (\* = *p* \< .05). Pound signs indicate significant differences between patient groups (^\#^ = p \< .05). Bold numbers indicate significant correlations over all participants. Reduced APT~w~^T1^ MTR~asym~ and its correlation with blood ammonia in cerebellar and occipital regions indicate either increased ammonia accumulation or hepatocerebral degeneration. Increased putaminal APT~w~^T1^ MTR~asym~ are related to other contrast mechanisms, such as strong alterations in metabolite concentrations.
